Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 2023; Volume 386,Issue 3

Viewpoint

  • You have access
    Could a Nebulized or Dry Powder Inhalation of a Dopamine D1R Agonist Be a Treatment of Idiopathic Pulmonary Fibrosis?
    Bradley T. Andresen
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 274-276; DOI: https://doi.org/10.1124/jpet.123.001661
  • You have access
    Dopamine Receptor D1 Is Exempt from Transforming Growth Factor β-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts
    Ashley Y. Gao, Ana M. Diaz Espinosa, Ba Bao N. Nguyen, Patrick A. Link, Jeffrey Meridew, Dakota L. Jones, Daniel F. Gibbard, Daniel J. Tschumperlin and Andrew J. Haak
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 277-287; DOI: https://doi.org/10.1124/jpet.122.001442

Minireview

  • Open Access
    Post-Transcriptional and Epigenetic Regulation of Estrogen Signaling
    Andrea Cignarella, Carlotta Boscaro, Mattia Albiero, Chiara Bolego and Matthias Barton
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 288-297; DOI: https://doi.org/10.1124/jpet.123.001613

Cardiovascular

  • Open Access
    Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome KATP Channel Mutations in Intact Cells
    Jian Gao, Conor McClenaghan, Kenneth A. Matreyek, Dorothy K. Grange and Colin G. Nichols
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 298-309; DOI: https://doi.org/10.1124/jpet.123.001659

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-<em>β</em>/Smad and RAF/ERK Pathways
    You have access
    The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-β/Smad and RAF/ERK Pathways
    Xiaocui Feng, Jianfeng Zhang, Runling Yang, Jingya Bai, Bochuan Deng, Lu Cheng, Feiyun Gao, Junqiu Xie and Bangzhi Zhang
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 310-322; DOI: https://doi.org/10.1124/jpet.123.001621

Metabolism, Transport, and Pharmacogenetics

  • You have access
    Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model
    Karolina H. Dziewulska, Julie A. Reisz, Ariel M. Hay, Angelo D’Alessandro and James C. Zimring
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 323-330; DOI: https://doi.org/10.1124/jpet.123.001634

Neuropharmacology

  • You have access
    Protein Kinase A Is Responsible for the Presynaptic Inhibition of Glycinergic and Glutamatergic Transmissions by Xenon in Rat Spinal Cord and Hippocampal CA3 Neurons
    Il-Sung Jang, Michiko Nakamura, Kiku Nonaka, Mami Noda, Naoki Kotani, Shutaro Katsurabayashi, Hideaki Nagami and Norio Akaike
    Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 331-343; DOI: https://doi.org/10.1124/jpet.123.001599
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 386 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 386, Issue 3
1 Sep 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Viewpoint
  • Minireview
  • Cardiovascular
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Metabolism, Transport, and Pharmacogenetics
  • Neuropharmacology
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics